
May 2, 2026
Parexel Acquires Vitrana to Expand AI-Enabled Pharmacovigilance Capabilities
Parexel has announced its acquisition of Vitrana, a move aimed at enhancing its pharmacovigilance capabilities through AI technology. This strategic integration is set to streamline patient safety operations within Parexel's clinical development framework.The acquisition will allow Parexel to incorporate Vitrana's versatile platform, which is compatible with various safety databases, into its existing systems. This integration is designed to facilitate comprehensive pharmacovigilance processes,
